Cargando…

Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity

BACKGROUND: Human recombinant erythropoietin (rHuEpo) that is used for the treatment of the chemotherapy-induced anaemia in cancer patients was shown to cause detrimental effects on the course of disease due to increased adverse events inflicting patient’s survival, potentially related to rHuEpo-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trost, Nina, Juvan, Peter, Sersa, Gregor, Debeljak, Natasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita, Warsaw 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472952/ https://www.ncbi.nlm.nih.gov/pubmed/23077460 http://dx.doi.org/10.2478/v10019-012-0037-8

Ejemplares similares

Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells
por: Trost, Nina, et al.
Publicado: (2013)

Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)

Erythropoietin and Its Angiogenic Activity
por: Kimáková, Patrícia, et al.
Publicado: (2017)

STAT5 as a Key Protein of Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021)

Molecular Insights into the Oxygen-Sensing Pathway and Erythropoietin Expression Regulation in Erythropoiesis
por: Tomc, Jana, et al.
Publicado: (2021)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Recombinant human Erythropoietin enhanced the cytotoxic effects of tamoxifen toward the spheroid MCF-7 breast cancer cells
por: Shujaa Edin, Hareth Y., et al.
Publicado: (2021)

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021)

The Clinical Impact of Recombinant Human Erythropoietin
por: Muirhead, N
Publicado: (1997)

Cross-platform transcriptomic profiling of the response to recombinant human erythropoietin
por: Wang, Guan, et al.
Publicado: (2021)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin
por: Parsons, Juliana, et al.
Publicado: (2013)

Preoperative recombinant human erythropoietin in anemic surgical patients
por: Monk, Terri G
Publicado: (2004)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]
por: Georgopoulos, Dimitris, et al.
Publicado: (2005)

Enhancement of Cytotoxicity of Cisplatin in vitro by Recombinant Human Tumor Necrosis Factor and/or Recombinant Human Interferon‐α, β and ‐γ
por: Kim, Chang‐Min, et al.
Publicado: (1989)

Results of Dynamic Contrast-Enhanced Ultrasound Correlate With Treatment Outcome in Canine Neoplasia Treated With Electrochemotherapy and Interleukin-12 Plasmid Electrotransfer
por: Brloznik, Maja, et al.
Publicado: (2021)

Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients
por: Hasegawa, Shun, et al.
Publicado: (2021)

Recombinant human erythropoietin for treating severe traumatic brain injury
por: Bai, Xiao-Fei, et al.
Publicado: (2018)

Modified aptamers as reagents to characterize recombinant human erythropoietin products
por: Jankowski, Wojciech, et al.
Publicado: (2020)

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia.
por: Barosi, G., et al.
Publicado: (1998)

Trends in Use, Cost, and Outcomes of Human Recombinant Erythropoietin, 1989-98
por: Greer, Joel W., et al.
Publicado: (1999)

Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013)

Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016)

Transcriptomic Markers of Recombinant Human Erythropoietin Micro-Dosing in Thoroughbred Horses
por: Dahlgren, Anna R., et al.
Publicado: (2021)

Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells
por: Fecková, Barbora, et al.
Publicado: (2019)

Recombinant human erythropoietin reduces plasminogen activator inhibitor and ameliorates pro-inflammatory responses following trauma
por: Shiehmorteza, M., et al.
Publicado: (2011)

Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG–PLA micelle
por: Shi, Yanan, et al.
Publicado: (2012)

Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
por: Ceelen, W, et al.
Publicado: (2007)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Expression and analysis of the glycosylation properties of recombinant human erythropoietin expressed in Pichia pastoris
por: Teh, Ser Huy, et al.
Publicado: (2011)

Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection
por: Sullivan, Patrick S, et al.
Publicado: (2011)

Effects of Recombinant Human Erythropoietin on Revascularization of Full Thickness Skin Grafts in Rat
por: Fatemi, Mohammad Javad, et al.
Publicado: (2014)

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.
por: Cascinu, S., et al.
Publicado: (1993)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

The Ergogenic Effect of Recombinant Human Erythropoietin on V̇O(2)max Depends on the Severity of Arterial Hypoxemia
por: Robach, Paul, et al.
Publicado: (2008)

Prolonged response to recombinant human erythropoietin treatment in patients with myelodysplastic syndrome at a single referral centre in Brazil
por: Moura, Anna Thawanny Gadelha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s4k9m6dm3oi5c0qgr91qr2qq9d